Kalypsys, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2001-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://kalypsys.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)
Phase 2
Completed
- Conditions
- Postherpetic NeuralgiaShinglesHerpes ZosterNeuropathic Pain
- Interventions
- Drug: Placebo gel
- First Posted Date
- 2007-12-18
- Last Posted Date
- 2008-07-22
- Lead Sponsor
- Kalypsys, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT00576108
- Locations
- 🇺🇸
United Bioscience Corporation, Kansas City, Missouri, United States
News
No news found